Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants-Reference-Cited by-同舟云学术

Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants

Published:2010-07 Issue:7 Volume:215 Page:570-578
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

del Rio Maria-Luisa,Kaye Jonathan,Rodriguez-Barbosa Jose-Ignacio

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference42 articles.

1. The role of TNF receptor and TNF superfamily molecules in organ transplantation;Adams;Am. J. Transplant.,2002

2. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation;Cai;Immunol. Rev.,2009

3. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses;Carreno;Annu. Rev. Immunol,2002

4. BTLA: a new inhibitory receptor with a B7-like ligand;Carreno;Trends Immunol,2003

5. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs;Chemnitz;J. Immunol.,2006

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth;2024-07-30

2. Targeting B and T lymphocyte attenuator regulates lupus disease development in NZB/W mice;2024-06-02

3. Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia;Biomolecules;2024-04-27

4. Progress in research and treatment of immune checkpoints in breast cancer;Asia-Pacific Journal of Oncology;2024-04-08

5. A Systematic Review of the Advances in the Study of T Lymphocyte Suppressor Receptors in HBV Infection: Potential Therapeutic Targets;Journal of Clinical Medicine;2024-02-21